Gait Analysis and Degenerative Spine
Launched by UNIVERSIDADE NOVA DE LISBOA · Mar 22, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a degenerative spinal disease affects the way people walk and move. Researchers want to understand how certain physical factors change as the disease progresses and how treatment might influence these changes. By studying these movements, they hope to learn more about the disease and improve care for patients.
To participate in this study, you need to be between 50 and 85 years old and have been diagnosed with a spinal disease for at least three months. It's important that you're able to speak Portuguese and can give your consent to join. Participants will be asked to go through some tests to analyze their walking and movement patterns. The study is currently recruiting, so if you or someone you know fits the criteria, this could be a valuable opportunity to contribute to research that may help others with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 50 and 85 years
- • Diagnosis of spinal disease by clinical and imagiological criteria
- • More than 3 months duration of disease
- • Ability to give consent
- • Fluent portuguese speaker
- Exclusion Criteria:
- • Previous spine surgery
- • Spinal instability
- • Neurological disease that might interfere with walking
- • Known orthopedic conditions that causes significant gait impairment
- • Dementia or development disorder with cognitive impairment
- • Inability to give consent
About Universidade Nova De Lisboa
Universidade Nova de Lisboa is a prominent academic institution dedicated to advancing knowledge and innovation in various fields, including healthcare and clinical research. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving patient outcomes and enhancing medical practices. Through its commitment to rigorous scientific methodology and ethical standards, Universidade Nova de Lisboa fosters an environment that promotes cutting-edge research and the development of new therapeutics, ultimately contributing to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lisbon, , Portugal
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported